Sigma-Aldrich Buys Biopharmaceutical Product Manufacturer MMB | GenomeWeb
NEW YORK (GenomeWeb News) - Sigma-Aldrich has acquired the biopharmaceutical contract manufacturer Molecular Medicine BioServices for an undisclosed amount of cash, Sigma said yesterday.
 
Sigma said it bought the Carlsbad, Calif.-based MMB to expand its SAFC Pharma business segment.
 
Sigma said MMB’s $12 million in annualized revenues will help it reach its growth goals, but will have a neutral impact on earnings in 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.